GUTS (fractyl.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Fractyl Health Inc. (GUTS)

The Fractyl Health, Inc. (GUTS) price chart on the GURU.Markets platform demonstrates the dynamics of the asset, which is currently valued at -6.83. The development of innovative therapy systems for metabolic disorders currently requires massive investment, which is temporarily increasing laboratory costs. The business relies on a staff of leading diabetologists attracted by generous stock options. Meanwhile, Fractyl Health, Inc. (GUTS) operates in a protected niche where demand for treatment remains independent of economic cycles.

GUTS Fractyl Health, Inc: Nilai Pasar marang Nilai Buku ing interval 21.02.2024 - 28.10.2026

Rincian metrik keuangan lan pasar Fractyl Health Inc. (GUTS)

- rega lan prakiraan konsensus rega:
Bagan rega Fractyl Health, Inc.|GUTS - Target median analis
- data kapitalisasi pasar:
Nilai pasar Fractyl|GUTS - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Fractyl Health|GUTS - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku fractyl.com|GUTS - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Fractyl Health, Inc.|GUTS - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Fractyl|GUTS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Fractyl
Analisis wiwitan perusahaan:Fractyl Health, Inc. - GUTS
Produk asli Fractyl

Fractyl Health, Inc. focuses on attracting leading biologists and researchers to develop its innovative platform. The market capitalization-to-book value ratio measures the market value premium over the issuer's net assets. The current value of -6.83 reflects investor expectations regarding the company's future breakthroughs. Exceeding industry norms signals potential returns alongside an increased risk of correction. The price action on the company's P/BV chart enables real-time benchmarking without waiting for quarterly reports.

Pesaing utama

Ascendis Pharma A/S - Rasio Nilai Pasar marang Nilai Buku|MDGL (madrigalpharma.com) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Corcept Therapeutics Incorporated CORT|Kapitalisasi Pasar marang Aset Bersih Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Metsera Therapeutics (MTSR)|Rasio Kapitalisasi Pasar marang Nilai Buku MLTX (MoonLake Immunotherapeutics)|crinetics.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Nilai Pasar marang Nilai Buku|FOLD (Amicus Pharma) - Rasio Nilai Pasar marang Nilai Buku|89bio Pharma (ETNB) - Rasio Kapitalisasi marang Aset Bersih|AGIO (Agios Pharmaceuticals) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku structuretx.com (GPCR)|MiMedx (MDXG) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku RZLT (Rezolute Inc)|Lexicon Pharma - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih MBX Corp MBX|ALT (Altimmune, Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|aardvarktherapeutics.com (AARD) - Koefisien Nilai Pasar marang Nilai Buku|SGMT - Rasio Kapitalisasi marang Aset Bersih|BioAge Labs (BIOA) - Multiplikator Kapitalisasi Pasar marang Nilai Buku|BMEA (Biomea) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Quince|Rasio Kapitalisasi Pasar marang Nilai Buku vTv Therapeutics Inc. (VTVT)|Rasio Nilai Pasar marang Nilai Buku ATPC (agapeatpgroup.com)|PLUR: Rasio Nilai Pasar marang Nilai Buku|Synlogic Inc. - Koefisien Nilai Pasar marang Nilai Buku|LPCN - Rasio Nilai Pasar marang Nilai Buku|MTNB - Rasio Nilai Pasar marang Nilai Buku|Spruce Biosciences - Rasio Kapitalisasi Pasar marang Nilai Buku|GLTO (galecto.com) - Kapitalisasi Pasar marang Nilai Buku|CTCX: Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku LUMO|Rasio Nilai Pasar marang Nilai Buku ONVO (Organovo Holdings Inc)|Rasio Kapitalisasi marang Aset Bersih Radius Pharmaceuticals (RDUS)